2025-02-11 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Executive Summary:**

Intuitive Surgical Inc. (ISRG) is a leading developer and manufacturer of robotic-assisted surgical systems.  This report analyzes ISRG's performance compared to the S&P 500 (VOO), recent price movements, key indicators (RSI, PPO), earnings, and financial information.  ISRG demonstrates significant outperformance against the benchmark, although recent data suggests potential moderation.


**1. Performance vs. S&P 500:**

ISRG's cumulative return is significantly higher than the S&P 500 (VOO).

* **ISRG Cumulative Return:** 331.74%
* **VOO Cumulative Return:** 120.05%
* **Return Difference:** 211.7% (94.9% of the historical range of the difference between ISRG and VOO)

This substantial outperformance is consistent across multiple years, as demonstrated by the high CAGR (Compound Annual Growth Rate) figures in the provided alpha and beta analysis.  However, the relative outperformance may be decreasing based on the most recent year's lower return rate.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 77.0% | 7.3% | 49.0% | -0.0 | 43.4 |
| 2016-2018  | 89.0% | 8.9% | 71.0% | 0.0 | 56.9 |
| 2017-2019  | 93.0% | 9.8% | 63.0% | 0.5 | 70.3 |
| 2018-2020  | 71.0% | 9.8% | 43.0% | 0.2 | 97.3 |
| 2019-2021  | 113.0% | 9.8% | 42.0% | 0.2 | 128.2 |
| 2020-2022  | 21.0% | 20.6% | 12.0% | 0.2 | 94.6 |
| 2021-2023  | 19.0% | 20.6% | -4.0% | 1.0 | 120.3 |
| 2022-2024  | 128.0% | 20.4% | 95.0% | 1.0 | 186.2 |
| 2023-2025  | 226.0% | 9.9% | 165.0% | 0.8 | 212.5 |


**2. Recent Price Movement:**

* **Closing Price:** $595.70
* **5-Day Moving Average:** $587.55
* **20-Day Moving Average:** $581.57
* **60-Day Moving Average:** $552.53

The price is above all three moving averages, suggesting a short-term uptrend.  The relatively large gap between the price and the 60-day moving average indicates a recent strong price increase. The price change from the previous close (+$2.18) shows a positive day-to-day momentum, though it's crucial to consider this in the context of longer term trends.


**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 45.82  - Suggests the stock is neither overbought nor oversold, but leaning towards the lower end of neutral.
* **PPO (Percentage Price Oscillator):** -0.11 - Indicates a slightly bearish momentum.
* **Delta_Previous_Relative_Divergence:** +4.3 - Shows a short-term upward trend.

The current price suggests a recent positive market movement, although the PPO suggests some weakening momentum.   The relatively high Expected Return of 19.2% (over S&P 500) suggests continued high potential, yet the technical indicators show potential for caution.

**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue       |
|------------|--------|---------------|
| 2024-10-18 | $1.59  | $2.04B        |
| 2024-07-19 | $1.48  | $2.01B        |
| 2024-04-19 | $1.54  | $1.89B        |
| 2023-10-20 | $1.18  | $1.74B        |
| 2024-10-18 | $1.18  | $1.74B        | *(Note: This line appears duplicated in the data)*

Revenue shows a generally upward trend, while EPS fluctuates.  The duplication in the data needs clarification.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.41B | 68.04%       |
| 2024-09-30 | $2.04B | 67.41%       |
| 2024-06-30 | $2.01B | 68.30%       |
| 2024-03-31 | $1.89B | 65.87%       |
| 2023-12-31 | $1.93B | 66.24%       |

Revenue is increasing, and profit margins remain consistently high, suggesting strong financial health.


**Capital and Profitability:**

| Quarter | Equity    | ROE     |
|---------|-----------|---------|
| 2024-12-31 | $16.43B  | 4.17%   |
| 2024-09-30 | $15.58B  | 3.63%   |
| 2024-06-30 | $14.71B  | 3.58%   |
| 2024-03-31 | $13.96B  | 3.90%   |
| 2023-12-31 | $13.31B  | 4.56%   |

Equity is growing, though ROE shows some fluctuation.


**6. Overall Analysis:**

ISRG demonstrates a history of strong performance significantly outpacing the S&P 500.  Recent price action shows a short-term uptrend, but indicators suggest a potential moderation in momentum.  Financials are strong, with high profit margins and growing revenue.  However, further investigation is needed to clarify the duplicated earnings data and to fully assess the sustainability of the high growth rate.  The high projected return (19.2% over S&P 500) should be considered alongside the less optimistic short-term indicators.  A long-term investment strategy may still be favorable, contingent upon the companyâ€™s ability to maintain its high growth rate.
